Ponatinib
Definition: Ponatinib, sold under the brand name Iclusig, is a medication used for the treatment of chronic myeloid leukemia and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia. It was developed by Ariad Pharmaceuticals. It is a multi-targeted tyrosine-kinase inhibitor. source: Wikipedia
- ID
- 703796003
- ID date
- 1 Oct 2014
- Previous ID
- 23560711000001106
- Name
- Ponatinib